HomeTCRX • NASDAQ
add
Tscan Therapeutics Inc
Previous close
$1.09
Day range
$1.05 - $1.11
Year range
$0.91 - $4.85
Market cap
61.29M USD
Avg Volume
952.12K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 2.51M | 139.37% |
Operating expense | 7.87M | 6.28% |
Net income | -35.71M | -19.48% |
Net profit margin | -1.42K | 50.08% |
Earnings per share | -0.28 | -12.00% |
EBITDA | -36.28M | -14.84% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 184.45M | -31.97% |
Total assets | 262.22M | -24.65% |
Total liabilities | 118.20M | -0.62% |
Total equity | 144.02M | — |
Shares outstanding | 56.75M | — |
Price to book | 0.43 | — |
Return on assets | -33.04% | — |
Return on capital | -36.11% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -35.71M | -19.48% |
Cash from operations | -32.46M | -16.28% |
Cash from investing | 32.58M | 139.56% |
Cash from financing | 0.00 | -100.00% |
Net change in cash | 112.00K | 100.10% |
Free cash flow | -24.60M | -24.36% |
About
Founded
2018
Headquarters
Website
Employees
146
